Delivery Order SPE2DB24D1021-SPE2DB25FFADG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, represents a non-set-aside competitive procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,789.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,125.38 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,137.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. This non-set-aside award, effective July 31, 2025, with completion targeted for August 1, 2025, represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $34,348.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,296.32 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count). This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $25,599.93, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFADGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,177.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, non-set-aside contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the DLA encompasses a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in supplying essential pharmaceuticals to support Defense Health Agency and other federal healthcare system requirements through the flexible DLA Troop Support Medical contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 9/2/25 |